Download PDF
Thromb Haemost 1983; 50(02): 604-609
DOI: 10.1055/s-0038-1665266
International Committee Communications
Schattauer GmbH Stuttgart

Retrospective Study on Complications and Adverse Effects of Treatment with Thrombin-Like Enzymes - A Multicentre Trial

Z S Latallo
The Department of Radiobiology, Institute of Nuclear Research, Warsaw, Poland
,
Participants of the trial: S. Balkuv-Ulutin, Istanbul, Turkey; J. F. Donahoe, North Chicago, USA; K. Fukutake, Tokyo, Japan; P. Griguerand M. Brochier, Tours, France; H. C. Kwaan, Chicago, U.S.A.; S. Lopaciukand J. A. Meissner, Warsaw, Poland; M. Martin, Engelskirchen, FRG; C. R. M. Prentice, G. D. 0. Lowe and C. D. Forbes, Glasgow, UK; A. A. Sharp, Oxford, UK; H. Vi nazzer, Linz, Austria; H. Wegner, Leipzig, GDR; E. Wenzel, Homburg/Saar, FRG, Data Processing and Computer Analysis: W. Borkowski, B. Swiatczak-Szenk, J. Kukowska and J. Labanowski › Author Affiliations
Further Information

Publication History

Received 01 April 1983

Accepted 10 May 1983

Publication Date:
18 July 2018 (online)

  PDF Download  Permissions and Reprints

Keywords

Treatment - Complications - Retrospective study
 

  • References

  • 1 Stocker K. Characterization of ancrod and batroxobin. In: Fibrinolytics and antifibrinolytics Markwardt F. (ed) Handbuch d. Experimentellen Pharmacologie 1978; 46: 454-484
    PubMedGoogle Scholar
  • 2 Kakkar VV, Flanc C, Howe CT, O’Shea M, Flute PT. Treatment of deep vein thrombosis. A trial of heparin, streptokinase and arvin Br Med J 1969; 1: 806-810
    CrossrefPubMedGoogle Scholar
  • 3 Davies JA, Merrick MV, Sharp AA, Holt JM. Controlled trial of ancrod and heparin in treatment of deep-vein thrombosis of lower limb. Lancet 1972; 1: 113-115
    PubMedGoogle Scholar
  • 4 Tibbutt DA, Williams EW, Walker MW, Chesterman CN, Holt JM, Sharp AA. Controlled trial of ancrod and streptokinase in the treatment of deep vein thrombosis of lower limb. Br J Haematol 1974; 27: 407-414
    CrossrefPubMedGoogle Scholar
  • 5 Leube G, Sondem W. Folia Angiologica 1975; 23: 411 op cit. In Prentice CR M, Lowe GD O, Belch JJ F, Forbes CD. The role of defibrinating agents in the treatment of vascular disorders. In: Vascular occlusion: Epidemiological, pathophysiological and therapeutics aspects Tesi M, Dormandy J. (eds) Serono Symposium 1981; 37: 399-404
    PubMedGoogle Scholar
  • 6 Martin M, Hirdes E, Auel H. Defibrinogenation treatment in patients suffering from severe intermittent claudication - a controlled study. Thromb Res 1976; 9: 47-57
    CrossrefPubMedGoogle Scholar
  • 7 Tonnesen KH, Sager PH, Gormsen J. Treatment of severe foot ischaemia by defibrination with ancrod: a randomized blind study. Scand J Clin Lab Invest 1978; 38: 431-435
    CrossrefPubMedGoogle Scholar
  • 8 Lowe GD O, Dunlop DJ, Lawson DH, Pollock JG, Watt JK, Forbes CD, Prentice CR M, Drummond MM. Double-blind controlled clinical trial of ancrod for ischemic rest pain of the leg. Angiology 1982; 33: 46-50
    CrossrefPubMedGoogle Scholar
  • 9 Wolf GK. Arvin in peripheral arterial circulatory disorders: controlled multicentre trials. Eur J Clin Pharmacol 1976; 9: 387-392
    CrossrefPubMedGoogle Scholar
  • 10 Lowe GD O, Morrice JJ, Fulton A, Forbes CD, Prentice CR M, Barbenel JC. Subcutaneous ancrod after operation for fractured hip - a dose-ranging and feasibility study. Thromb Haemostas 1978; 40: 134-143
    PubMedGoogle Scholar
  • 11 Belch JJ F, Meek DR, Lowe GD O, Campbell AF, Young AB, Forbes CD, Prentice CR M. Subcutaneous ancrod in prevention of deep vein thrombosis after hip replacement surgery. Thromb Res 1982; 25: 23-31
    CrossrefPubMedGoogle Scholar
  • 12 Latallo ZS. Report of the task force on clinical use of snake venom enzymes. Thromb Haemostas 1978; 39: 768-774
    PubMedGoogle Scholar
  • 13 Kakkar VV, Howe CT, Flanc C, Clarke MB. Natural history of postoperative deep-vein thrombosis. Lancet 1969; 2: 230-232
    CrossrefPubMedGoogle Scholar
  • 14 Thomas DP. Heparin in the prophylaxis and treatment of venous thromboembolism. Semin Hematol 1978; 15: 1-17
    PubMedGoogle Scholar
  • 15 Urokinase Pulmonary Embolism Trial Study Group. Urokinase pulmonary embolism trial. Phase 1 results. A cooperative study. JAMA. 1970 214. 2163-2172
    PubMedGoogle Scholar
  • 16 Salzman EW, Deykin D, Shapiro RM, Rosenberg R. Management of heparin therapy - controlled prospective trial. N Engl J Med 1975; 292: 1046-1051
    CrossrefPubMedGoogle Scholar
  • 17 Latallo ZS, Lopaciuk S. New approach to thrombolytic therapy. The use of defibrase in connection with streptokinase Thrombos Diathes Haemorrh 1973; Suppl 56: 253-255
    PubMedGoogle Scholar
  • 18 Carreras LO. Thrombosis and thrombocytopenia induced by heparin. In Clinical usage of heparin. Present and future trends Verstraete M, Machin SJ. (eds) 1980; pp 64-80
    PubMedGoogle Scholar
  • 19 Bell WR, Tomasulo PA, Alving BM, Duffy TP. Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients Ann Intern Med 1976; 85: 155-160
    CrossrefPubMedGoogle Scholar
  • 20 Nelson JC, Lemer RG, Goldstein R, Cagin NA. Heparin-induced thrombocytopenia. Arch Intern Med 1978; 138: 548-552
    CrossrefPubMedGoogle Scholar
  • 21 Barlow GH, Lewis LJ, Finley R, Martin D, Stocker K. Immunochemical identification of ancrod (A38414) and reptilase (defibrase). Thromb Res 1973; 2: 17-22
    CrossrefPubMedGoogle Scholar